AAPP 2024 Schedule

Enjoy browsing through all that the AAPP 2024 Annual Meeting has to offer!

Customize your schedule by bookmarking sessions of interest using the bookmark () buttons. Then, filter the list below.

Sunday, April 7, 2024

-
Evaluation not yet available: Transforming Mental Health Systems: Lessons from the Global South You are ineligible: Transforming Mental Health Systems: Lessons from the Global South Evaluation complete: Transforming Mental Health Systems: Lessons from the Global South
Transforming Mental Health Systems: Lessons from the Global South 1.00h ACPE
Vikram Patel, MBBS, PhD
International
-
Evaluation not yet available: Evidence-based Management of Borderline Personality Disorder You are ineligible: Evidence-based Management of Borderline Personality Disorder Evaluation complete: Evidence-based Management of Borderline Personality Disorder
Evidence-based Management of Borderline Personality Disorder 1.00h ACPE BCPP
Katharine "Kaz" Joyer Nelson, MD, DFAPA
International
-
Evaluation not yet available: Role of Cannabis and Cannabidiol in the Treatment of Anxiety Disorders You are ineligible: Role of Cannabis and Cannabidiol in the Treatment of Anxiety Disorders Evaluation complete: Role of Cannabis and Cannabidiol in the Treatment of Anxiety Disorders
Role of Cannabis and Cannabidiol in the Treatment of Anxiety Disorders 1.00h ACPE BCPP
Tiffany R Buckley, PharmD, BCPS, BCPP
International

Monday, April 8, 2024

-
Evaluation not yet available: Integrating Contraceptive Care in Psychiatry: Best Practices You are ineligible: Integrating Contraceptive Care in Psychiatry: Best Practices Evaluation complete: Integrating Contraceptive Care in Psychiatry: Best Practices
Integrating Contraceptive Care in Psychiatry: Best Practices 1.25h ACPE
Veronica Vernon, PharmD, BCPS, BCACP, MSCP
International
-
Evaluation not yet available: Insomnia: Treatment Resistance and Special Populations You are ineligible: Insomnia: Treatment Resistance and Special Populations Evaluation complete: Insomnia: Treatment Resistance and Special Populations
Insomnia: Treatment Resistance and Special Populations 1.25h ACPE
Megan Maroney, PharmD, BCPP
International
-
Concurrent session
Evaluation not yet available: The Good, the Bad, and the Unknown of Psychotropic Stewardship Implementation: A Focus on Antipsychotics You are ineligible: The Good, the Bad, and the Unknown of Psychotropic Stewardship Implementation: A Focus on Antipsychotics Evaluation complete: The Good, the Bad, and the Unknown of Psychotropic Stewardship Implementation: A Focus on Antipsychotics
The Good, the Bad, and the Unknown of Psychotropic Stewardship Implementation: A Focus on Antipsychotics 1.00h ACPE BCPP
Chelsea Di Polito, PharmD, BCPP
IB II-III
-
Concurrent session
Evaluation not yet available: Anticholinergic Deprescribing: What We Don’t Know You are ineligible: Anticholinergic Deprescribing: What We Don’t Know Evaluation complete: Anticholinergic Deprescribing: What We Don’t Know
Anticholinergic Deprescribing: What We Don’t Know 1.00h ACPE
Noll L. Campbell, PharmD, MS
IB I
-
Concurrent session
Evaluation not yet available: Addressing Ambivalence and Non-Adherence to Mental Health Treatment You are ineligible: Addressing Ambivalence and Non-Adherence to Mental Health Treatment Evaluation complete: Addressing Ambivalence and Non-Adherence to Mental Health Treatment
Addressing Ambivalence and Non-Adherence to Mental Health Treatment 1.00h ACPE BCPP
Russell E. Spieth, MEd, PhD
IB II-III
-
Concurrent session
Evaluation not yet available: Management of Clozapine-Resistant Schizophrenia You are ineligible: Management of Clozapine-Resistant Schizophrenia Evaluation complete: Management of Clozapine-Resistant Schizophrenia
Management of Clozapine-Resistant Schizophrenia 1.00h ACPE
Megan J. Ehret, PharmD, MS, BCPP
IB I
-
Concurrent session
Evaluation not yet available: Social Determinants of Health in the Treatment of Depression You are ineligible: Social Determinants of Health in the Treatment of Depression Evaluation complete: Social Determinants of Health in the Treatment of Depression
Social Determinants of Health in the Treatment of Depression 1.00h ACPE
Shari N. Allen, PharmD, BCPP
IB I
-
Concurrent session
Evaluation not yet available: Using Pharmacogenomics to Optimize Mental Health Comprehensive Medication Management You are ineligible: Using Pharmacogenomics to Optimize Mental Health Comprehensive Medication Management Evaluation complete: Using Pharmacogenomics to Optimize Mental Health Comprehensive Medication Management
Using Pharmacogenomics to Optimize Mental Health Comprehensive Medication Management 1.00h ACPE BCPP
Kristen Ward, PharmD, BCPP
IB II-III

Tuesday, April 9, 2024

-
Evaluation not yet available: Industry Showcase UZEDY: An LAI With a Spectrum of Key Attributes for the Treatment of Schizophrenia Supported by Teva Pharmaceutical You are ineligible: Industry Showcase UZEDY: An LAI With a Spectrum of Key Attributes for the Treatment of Schizophrenia Supported by Teva Pharmaceutical Evaluation complete: Industry Showcase UZEDY: An LAI With a Spectrum of Key Attributes for the Treatment of Schizophrenia Supported by Teva Pharmaceutical
Industry Showcase UZEDY: An LAI With a Spectrum of Key Attributes for the Treatment of Schizophrenia Supported by Teva Pharmaceutical Free Public Registration
Ilan Melnick, MD
National A
-
Evaluation not yet available: Psychedelics: Ethics and Real World Applications You are ineligible: Psychedelics: Ethics and Real World Applications Evaluation complete: Psychedelics: Ethics and Real World Applications
Psychedelics: Ethics and Real World Applications 1.25h ACPE
Greg A. Fonzo, Ph.D.
International
-
Evaluation not yet available: Living Through Loss - Navigating Loss by Suicide as a Clinician-Survivor You are ineligible: Living Through Loss - Navigating Loss by Suicide as a Clinician-Survivor Evaluation complete: Living Through Loss - Navigating Loss by Suicide as a Clinician-Survivor
Living Through Loss - Navigating Loss by Suicide as a Clinician-Survivor 1.25h ACPE
Julie Cerel, PhD
International
-
Evaluation not yet available: Industry Symposium With ACPE Credit A New Script: Implementing Prescription Digital Therapeutics into Practice Supported by Boehringer Ingelheim You are ineligible: Industry Symposium With ACPE Credit A New Script: Implementing Prescription Digital Therapeutics into Practice Supported by Boehringer Ingelheim Evaluation complete: Industry Symposium With ACPE Credit A New Script: Implementing Prescription Digital Therapeutics into Practice Supported by Boehringer Ingelheim
Industry Symposium With ACPE Credit A New Script: Implementing Prescription Digital Therapeutics into Practice Supported by Boehringer Ingelheim ACPE Free Public Registration
Kari Franson, PharmD, PhD, BCPP
National A
-
Concurrent session
Evaluation not yet available: Approaches to Managing Psychogenic Non-Epileptic Seizures (PNES) You are ineligible: Approaches to Managing Psychogenic Non-Epileptic Seizures (PNES) Evaluation complete: Approaches to Managing Psychogenic Non-Epileptic Seizures (PNES)
Approaches to Managing Psychogenic Non-Epileptic Seizures (PNES) 1.00h ACPE
Austin De La Cruz, PharmD, BCPP
IB III
-
Concurrent session
Evaluation not yet available: Clinical Pearls 1 You are ineligible: Clinical Pearls 1 Evaluation complete: Clinical Pearls 1
Clinical Pearls 1 1.00h ACPE
Shari N. Allen, PharmD, BCPP; Ahmaya Mustafa, PharmD, BCPS, BCPP; Audrey Abelleira, PharmD, BCPS, BCPP
IB II
-
Concurrent session
Evaluation not yet available: Comprehensive Management of Psychiatric Medication Overdose You are ineligible: Comprehensive Management of Psychiatric Medication Overdose Evaluation complete: Comprehensive Management of Psychiatric Medication Overdose
Comprehensive Management of Psychiatric Medication Overdose 1.00h ACPE
Nena Bowman, PharmD, DABAT
IB I
-
Concurrent session
Evaluation not yet available: RLS Management and Psychiatric Comorbidity Considerations You are ineligible: RLS Management and Psychiatric Comorbidity Considerations Evaluation complete: RLS Management and Psychiatric Comorbidity Considerations
RLS Management and Psychiatric Comorbidity Considerations 1.00h ACPE
Arthur Walters, MD
IB III
-
Concurrent session
Evaluation not yet available: Clinical Pearls 2 You are ineligible: Clinical Pearls 2 Evaluation complete: Clinical Pearls 2
Clinical Pearls 2 1.00h ACPE
Ericka Crouse, PharmD, BCPP, BCGP; Ashley Maister, PharmD, BCPP; Christine Rarrick, PharmD, MBA, BCPS, BCPP
IB II
-
Concurrent session
Evaluation not yet available: Identification and Management of Illicit Substance Use (xylazine, fentanyl, kratom) You are ineligible: Identification and Management of Illicit Substance Use (xylazine, fentanyl, kratom) Evaluation complete: Identification and Management of Illicit Substance Use (xylazine, fentanyl, kratom)
Identification and Management of Illicit Substance Use (xylazine, fentanyl, kratom) 1.00h ACPE
Steven W. Shoyer, PharmD, BCPP
IB I

Wednesday, April 10, 2024

-
Evaluation not yet available: Palliative Psychiatry for Severe, Persistent Mental Illness You are ineligible: Palliative Psychiatry for Severe, Persistent Mental Illness Evaluation complete: Palliative Psychiatry for Severe, Persistent Mental Illness
Palliative Psychiatry for Severe, Persistent Mental Illness 1.00h ACPE
Diana V. Punko, MD, MS
International
-
Evaluation not yet available: Gun Violence: Impact on Mental Health You are ineligible: Gun Violence: Impact on Mental Health Evaluation complete: Gun Violence: Impact on Mental Health
Gun Violence: Impact on Mental Health 1.00h ACPE
Howard Pinderhughes, PhD
International
-
Evaluation not yet available: Psychiatric and Neurologic Medication Pipeline You are ineligible: Psychiatric and Neurologic Medication Pipeline Evaluation complete: Psychiatric and Neurologic Medication Pipeline
Psychiatric and Neurologic Medication Pipeline 1.00h ACPE
Stephen R. Saklad, PharmD, BCPP
International